Opportunity Information: Apply for TI 16 010
Apply for TI 16 010
- The HHS-SAMHS in the health sector is offering a public funding opportunity titled "Program Supplements for Violence Intervention to Enhance Lives (Short Title: VITEL)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243.
- This funding opportunity was created on Apr 05, 2016 and posted on Apr 05, 2016.
- Applicants must submit their applications by Jun 06, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $70,000.00 in funding.
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Program Supplements for Violence Intervention to Enhance Lives (VITEL) is a SAMHSA initiative administered through the Center for Substance Abuse Treatment (CSAT) that offers one-year supplemental grant funding to a very specific set of existing grantees. Rather than being a broad, open competition, this opportunity is designed as an add-on to expand and strengthen work already underway under the Targeted Capacity Expansion Substance Abuse Treatment for Racial/Ethnic Minority Women at High Risk for HIV/AIDS program (TCE-HIV Minority Women). Eligibility is limited to the cohort of TCE-HIV Minority Women grantees originally funded in FY 2014 under RFA TI-13-011, meaning only those current awardees can apply for this supplement.
The core purpose of the supplement is to enhance existing substance use disorder (SUD) treatment and related HIV-focused services by integrating intimate partner violence (IPV) screening into service delivery. VITEL recognizes that IPV can directly shape substance use risk, treatment engagement, and HIV vulnerability, and it funds participating programs to add routine screening and build stronger pathways for referral and follow-up when IPV is identified. The supplement is funded through the Secretarys Minority AIDS Initiative Fund (SMAIF), reflecting its focus on reducing HIV impacts and disparities in communities that are disproportionately affected.
The underlying TCE-HIV Minority Women program targets African American, Hispanic/Latina, and other racial/ethnic minority women ages 18 and older who have SUD and/or co-occurring substance use and mental disorders and who are living with HIV/AIDS or are at risk. The population of focus is explicitly inclusive of heterosexual, lesbian, and bisexual women, women who were previously incarcerated, and their significant others. VITEL does not replace those goals; it adds a violence-intervention component to existing treatment and HIV service models in order to better address real-world conditions that often contribute to relapse, unsafe sexual practices, barriers to care, and poorer health outcomes.
VITEL lays out five program goals that clarify what the supplement is meant to accomplish through IPV screening. First, it aims to reduce IPV by identifying it through screening and connecting clients to appropriate referrals. Second, it seeks to reduce risky behaviors associated with new HIV infections and with substance use disorders, acknowledging that violence exposure can increase risk-taking and reduce a persons ability to negotiate safety. Third, it is intended to increase access to care and improve health outcomes for people living with HIV and AIDS by making behavioral health settings more responsive to violence-related needs. Fourth, it targets the reduction of HIV-related health disparities by building IPV screening tools into routine practice, with the idea that consistent identification and referral can improve outcomes for groups that experience disproportionate HIV burden. Fifth, it explicitly includes a learning objective: determining the feasibility of integrating IPV screening in behavioral health settings, which implies attention to practical implementation issues such as workflow, staff capacity, client safety, confidentiality, and referral coordination.
From an administrative standpoint, this is a discretionary grant opportunity (CFDA 93.243) with an award ceiling of $70,000 per recipient and an expectation of five awards total. The funding period is one year, and the opportunity was posted on April 5, 2016 with an application closing date of June 6, 2016. The funding opportunity number is TI 16 010. Overall, VITEL is best understood as a targeted, time-limited supplement intended to help a small number of established HIV and SUD treatment grantees add a structured IPV screening and referral capability, with the broader aim of improving safety, health outcomes, and equity for racial and ethnic minority women affected by substance use and HIV.
Program Supplements for Violence Intervention to Enhance Lives (VITEL) - FAQs
What is the VITEL grant opportunity?
Program Supplements for Violence Intervention to Enhance Lives (VITEL) is a SAMHSA initiative administered through the Center for Substance Abuse Treatment (CSAT) that provides one-year supplemental funding to expand and strengthen work already being done by a very specific set of existing SAMHSA grantees.
Is VITEL an open competition?
No. VITEL is not a broad, open competition. It is an add-on (supplement) opportunity intended only for eligible current grantees to enhance an already-funded project.
Who is eligible to apply for VITEL?
Eligibility is limited to the cohort of Targeted Capacity Expansion Substance Abuse Treatment for Racial/Ethnic Minority Women at High Risk for HIV/AIDS (TCE-HIV Minority Women) grantees originally funded in FY 2014 under RFA TI-13-011. Only those current awardees can apply for this supplement.
Which existing program does VITEL supplement?
VITEL supplements the TCE-HIV Minority Women program (Targeted Capacity Expansion Substance Abuse Treatment for Racial/Ethnic Minority Women at High Risk for HIV/AIDS).
What is the main purpose of the VITEL supplement?
The core purpose is to enhance existing substance use disorder (SUD) treatment and related HIV-focused services by integrating intimate partner violence (IPV) screening into service delivery and strengthening referral and follow-up pathways when IPV is identified.
What specific service enhancement does VITEL emphasize?
VITEL emphasizes adding routine IPV screening within behavioral health service settings and building stronger processes for referral and follow-up for clients who screen positive or disclose IPV.
Why does VITEL focus on intimate partner violence (IPV) in SUD and HIV-related services?
VITEL recognizes that IPV can directly influence substance use risk, treatment engagement, and HIV vulnerability. Integrating screening is intended to make services more responsive to violence-related needs that can affect safety and health outcomes.
Who is the population of focus under the underlying TCE-HIV Minority Women program?
The underlying program targets African American, Hispanic/Latina, and other racial/ethnic minority women ages 18 and older who have SUD and/or co-occurring substance use and mental disorders and who are living with HIV/AIDS or are at risk.
Does the target population include different sexual orientations?
Yes. The population of focus is explicitly inclusive of heterosexual, lesbian, and bisexual women.
Does the target population include women who were previously incarcerated?
Yes. The population of focus explicitly includes women who were previously incarcerated.
Does the program also consider the needs of clients significant others?
Yes. The population of focus includes the significant others of the women served.
Does VITEL replace the goals of the TCE-HIV Minority Women program?
No. VITEL does not replace the underlying programs goals. It adds a violence-intervention component (IPV screening and referral capability) to existing treatment and HIV service models.
What are the program goals of VITEL?
VITEL outlines five program goals:
- Reduce IPV by identifying it through screening and connecting clients to appropriate referrals.
- Reduce risky behaviors associated with new HIV infections and with substance use disorders.
- Increase access to care and improve health outcomes for people living with HIV and AIDS by making behavioral health settings more responsive to violence-related needs.
- Reduce HIV-related health disparities by integrating IPV screening tools into routine practice.
- Determine the feasibility of integrating IPV screening in behavioral health settings (including practical implementation considerations).
How does VITEL aim to reduce IPV?
By building IPV identification into routine screening and connecting individuals to appropriate referrals and follow-up when IPV is identified.
How does IPV screening relate to HIV and SUD risk reduction in this program?
VITEL acknowledges that exposure to violence can increase risk-taking behaviors and reduce a persons ability to negotiate safety, which can contribute to new HIV infections and substance use-related risks. Screening and referral are intended to help address these factors.
How does VITEL aim to improve outcomes for people living with HIV/AIDS?
It aims to improve access to care and health outcomes by making behavioral health settings more responsive to violence-related needs that can create barriers to treatment engagement and follow-through.
How does VITEL address HIV-related health disparities?
By integrating IPV screening tools into routine practice, with the goal that consistent identification and referral can improve outcomes for groups experiencing disproportionate HIV burden.
What does the feasibility goal imply for implementation?
The feasibility goal implies attention to practical considerations involved in integrating IPV screening into behavioral health settings, including workflow, staff capacity, client safety, confidentiality, and referral coordination.
What is the funding source for VITEL?
The supplement is funded through the Secretarys Minority AIDS Initiative Fund (SMAIF), reflecting a focus on reducing HIV impacts and disparities in disproportionately affected communities.
What is the type of grant and the CFDA number?
This is a discretionary grant opportunity. The CFDA number is 93.243.
What is the maximum award amount per recipient?
The award ceiling is $70,000 per recipient.
How many awards are expected?
There is an expectation of five awards total.
How long is the funding period?
The funding period is one year.
What is the funding opportunity number for VITEL?
The funding opportunity number is TI 16 010.
When was the opportunity posted and when did it close?
The opportunity was posted on April 5, 2016, and the application closing date was June 6, 2016.
In one sentence, how should this opportunity be understood?
VITEL is a targeted, time-limited supplement for a small number of established HIV and SUD treatment grantees to add structured IPV screening and referral capability to improve safety, health outcomes, and equity for racial and ethnic minority women affected by substance use and HIV.
Browse more opportunities from the same category: Health
Next opportunity: BLM Utah Arid Land/Rehabilitation of Soils Study
Previous opportunity: Health Information Technologies and Informatics Hands-Free
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for TI 16 010
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (TI 16 010) also looked into and applied for these:
| Funding Opportunity |
|---|
| Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) Apply for PA 16 163 Funding Number: PA 16 163 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Emerging Infections Programs Apply for CDC RFA CK17 1701 Funding Number: CDC RFA CK17 1701 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| CDC’s Collaboration with Academia to Strengthen Public Health Workforce Capacity Apply for CDC RFA OE12 120105CONT16 Funding Number: CDC RFA OE12 120105CONT16 Agency: HHS-CDC-CSELS Category: Health Funding Amount: Case Dependent |
| Establishment of Resource Centers for Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24) Apply for RFA DE 17 001 Funding Number: RFA DE 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $2,500,000 |
| American Indians into Nursing Apply for HHS 2016 IHS NU 0001 Funding Number: HHS 2016 IHS NU 0001 Agency: HHS-IHS Category: Health Funding Amount: $400,000 |
| PPHF 2016: Prevention Health and Health Services Block Grants – Behavioral Risk Factor Surveillance System, (BRFSS) – Financed in part by 2016 Prevention and Public Health Funds Apply for CDC RFA DP15 151302CONTPPHF16 Funding Number: CDC RFA DP15 151302CONTPPHF16 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: Case Dependent |
| Training and Technical Assistance for Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color At Risk for and Living with HIV Infection Apply for CDC RFA PS15 151002CONT16 Funding Number: CDC RFA PS15 151002CONT16 Agency: HHS-CDC-NCHHSTP Category: Health Funding Amount: Case Dependent |
| “Extension of the World Trade Center Health Registry (50)” Apply for RFA OH 16 001 Funding Number: RFA OH 16 001 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| Strengthening sustainable public health capacity in the Eastern Mediterranean Region for polio eradication and routine immunization activities Apply for CDC RFA GH16 160102CONT16 Funding Number: CDC RFA GH16 160102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Building Public Health Capacity for Drought Response Apply for CDC RFA EH16 1603 Funding Number: CDC RFA EH16 1603 Agency: HHS-CDC-NCEH Category: Health Funding Amount: $150,000 |
| NEI Research Grant for Vision Related Secondary Data Analysis (R21) Apply for PAR 16 168 Funding Number: PAR 16 168 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Educating State-level Stakeholders on Strategies to Address Winnable Battles in Public Health Apply for CDC RFA SO15 150102CONT16 Funding Number: CDC RFA SO15 150102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Identification of Small Molecules for Sustained-Release Anti-HIV Products (R01) Apply for RFA AI 16 024 Funding Number: RFA AI 16 024 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Advancing HIV Therapeutic Vaccine Science (U01) Apply for RFA AI 16 019 Funding Number: RFA AI 16 019 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Human Tissue Models for Infectious Diseases (U19) Apply for RFA AI 16 022 Funding Number: RFA AI 16 022 Agency: HHS-NIH11 Category: Health Funding Amount: $1,000,000 |
| Noise-Induced Cochlear Synaptopathy: Basic Studies Informing Potential Therapies (R01) Apply for PAR 16 170 Funding Number: PAR 16 170 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| Innovation for HIV Vaccine Discovery (R01) Apply for PAR 16 171 Funding Number: PAR 16 171 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: IDeA (Institutional Development Award) Core Optimization (Admin Supp) Apply for PA 16 172 Funding Number: PA 16 172 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Research Partnerships for Scaling Up Mental Health Interventions in Low-and Middle-Income Countries (U19) Apply for PAR 16 174 Funding Number: PAR 16 174 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| Affordable Care Act Program for Early Detection of Certain Medical Conditions Related to Environmental Health Hazards Apply for CDC RFA TS15 150102CONT16 Funding Number: CDC RFA TS15 150102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "TI 16 010", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.